Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 30, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2017

Conditions
Immune Reconstitution Inflammatory SyndromeHIVTuberculosis
Interventions
DRUG

Prednisone

DRUG

Placebo

Trial Locations (1)

7784

Site B Khayelitsha HIV/TB clinic, Cape Town

All Listed Sponsors
collaborator

Institute of Tropical Medicine, Belgium

OTHER

collaborator

Imperial College London

OTHER

collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

collaborator

Department of Science and Technology, South Africa

UNKNOWN

lead

University of Cape Town

OTHER

NCT01924286 - Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone | Biotech Hunter | Biotech Hunter